Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

VERADIGM INC

MDRXOTCEQUITYCurrent

Changes in Beneficial Ownership

Filed Jun 3, 2026Accepted Jun 3, 2026, 4:30 PM EDTFiling CIK 1124804Accession 0001193125-26-255558
Share

Structured filing — 4

ownership.xml

Open full document ↗

Filing details

Report period
2026-06-01
Issuer
Veradigm Inc.
Issuer CIK
0001124804
Trading symbol
MDRX

Reporting owner 1

Name
SILVERMAN LOU
Reporting owner CIK
0001249935
Relationship
Director
Address
222 MERCHANDISE MART, SUITE 2024, CHICAGO, IL, 60654

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
Common Stock2026-06-01A · Form 4[F1]42,507A0.0099,131D
Table key
A · Form 4
Acquisition by grant, award or otherwise under Rule 16b-3(d)
A
Acquired
D
Direct

Footnotes

F1
Award of Restricted Stock Units granted under the Veradigm Inc. Amended and Restated 2024 Stock Incentive Plan on June 1, 2026 (the "Grant Date"). The grant vests 100% on the first anniversary of the Grant Date.↩ 1

Signature 1

Signed
/s/Lisa Zvonik by power of attorney for Lou Silverman
Date
2026-06-03

Company context

Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent practices improve outcomes and financial performance. Our AI-forward data and technology also help over 20,000 provider practices connect with health plans and biopharma to eliminate inefficiencies, close care gaps, and create a more affordable health system. © 2026 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or Company names are the property of their respective holders, all rights reserved.

Current securities

Historical securities (1)

Recent company filings

  1. NT 10-Q filingNov 10, 2026
  2. Regulation FD DisclosureSep 15, 2026
  3. Other EventsSep 8, 2026
  4. Regulation FD DisclosureSep 8, 2026
  5. Regulation FD DisclosureAug 17, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.